Literature DB >> 29782904

Intracellular S1P Levels Dictate Fate of Different Regions of the Hippocampus following Transient Global Cerebral Ischemia.

Sherif Rashad1, Kuniyasu Niizuma2, Daisuke Saigusa3, Xiaobo Han4, Mika Sato-Maeda4, Ritsumi Saito5, Akira Uruno5, Miki Fujimura4, Shuntaro Ikawa6, Masayuki Yamamoto5, Teiji Tominaga4.   

Abstract

Sphingosine-1-phosphate (S1P) is a sphingolipid molecule produced by the action of sphingosine kinases (SphK) on sphingosine. It possesses various intracellular functions through its interactions with intracellular proteins or via its action on five G-protein-coupled cell membrane receptors. Following transient global cerebral ischemia (tGCI), only the CA1 subregion of the hippocampus undergoes apoptosis. In this study, we evaluated S1P levels and S1P-processing enzyme expression in different hippocampal areas following tGCI in rats. We found that S1P was upregulated earlier in CA3 than in CA1. This was associated with upregulation of SphK1 in both regions; however, SphK2 was downregulated quickly in CA3. S1P lyase was also downregulated in CA3, but not in CA1. Spinster 2, the S1P exporter, was upregulated early in both regions, but was quickly downregulated in CA3. Together, these effects explain the variable levels of S1P in the CA1 and CA3 areas and indicate that S1P levels play a role in the preferential resistance of the CA3 subregion to tGCI-induced ischemia. FTY720 did not improve neuronal survival in the CA1 subregion, indicating that these effects were due to intracellular S1P accumulation. In conclusion, the findings suggest that intracellular S1P levels affect neuronal cell fate following tGCI.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  S1P; apoptosis; global cerebral ischemia; sphingosine-1-phosphate; spinster 2

Mesh:

Substances:

Year:  2018        PMID: 29782904     DOI: 10.1016/j.neuroscience.2018.05.015

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.

Authors:  Melissa A Maczis; Michael Maceyka; Michael R Waters; Jason Newton; Manjulata Singh; Madisyn F Rigsby; Tia H Turner; Mohammad A Alzubi; J Chuck Harrell; Sheldon Milstien; Sarah Spiegel
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

2.  Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach.

Authors:  Sherif Rashad; Daisuke Saigusa; Takahiro Yamazaki; Yotaro Matsumoto; Yoshihisa Tomioka; Ritsumi Saito; Akira Uruno; Kuniyasu Niizuma; Masayuki Yamamoto; Teiji Tominaga
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

3.  Sphingolipid metabolism governs Purkinje cell patterned degeneration in Atxn1[82Q]/+ mice.

Authors:  François G C Blot; Wilhelmina H J J Krijnen; Sandra Den Hoedt; Catarina Osório; Joshua J White; Monique T Mulder; Martijn Schonewille
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.